Eastwood Bio-Medical Canada Inc. (TSXV:EBM)

Revenue by Segment

Financials in millions CAD. Fiscal year is November - October.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2018	Oct 31, 2017	Oct 31, 2016
Distribution of Eleotin® and Related Products	782.08K	702.08K	867.94K	1.30M	981.05K
Distribution of Eleotin® and Related Products Growth	11.40%	-19.11%	-33.22%	32.49%	36.57%
Total	782.08K	702.08K	867.94K	1.30M	981.05K
Total Growth	11.40%	-19.11%	-33.22%	32.49%	36.57%

Revenue by Geography

Financials in millions CAD. Fiscal year is November - October.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2018	Oct 31, 2017	Oct 31, 2016
Asia	619.49K	435.72K	616.23K	927.15K	584.46K
Asia Growth	42.17%	-29.29%	-33.53%	58.64%	68.18%
Canada	86.26K	138.34K	112.83K	203.55K	199.64K
Canada Growth	-37.65%	22.61%	-44.57%	1.96%	6.58%
United States (U.S.)	76.34K	128.01K	138.87K	169.06K	196.96K
United States (U.S.) Growth	-40.37%	-7.82%	-17.86%	-14.16%	7.33%
Total	782.08K	702.08K	867.94K	1.30M	981.05K
Total Growth	11.40%	-19.11%	-33.22%	32.49%	36.57%

Data Source: S&P Global Market Intelligence Last updated: Jan 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error